{"id":60220,"date":"2024-10-04T12:00:29","date_gmt":"2024-10-04T12:00:29","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/10\/04\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/"},"modified":"2024-10-04T12:00:29","modified_gmt":"2024-10-04T12:00:29","slug":"lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/","title":{"rendered":"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock"},"content":{"rendered":"<div>\n<p><em>PIPE with New and Existing Investors Supports Working Capital and Operations<\/em><\/p>\n<p align=\"left\">CHASKA, Minn., Oct.  04, 2024  (GLOBE NEWSWIRE) &#8212; Lifecore Biomedical, Inc. (\u201cLifecore\u201d), a fully integrated contract development and manufacturing organization (\u201cCDMO\u201d), today announced the closing of a $24.3 million private placement (\u201cPIPE\u201d) of 5,928,775 shares of its common stock at a price of $4.10 per share. The investing group includes new and existing shareholders, and the company expects to use the proceeds for working capital, operations, and general corporate purposes.<\/p>\n<p>\u201cWe are very pleased to have the confidence of these new and long-term stockholders, which we believe reflects their support for our new management team, our plan for value creation, and the tremendous opportunity we have in this growing market,\u201d commented Paul Josephs, president and chief executive officer of Lifecore.<\/p>\n<p><strong>Important Information Regarding the Common Stock<\/strong><\/p>\n<p>The common stock was issued in reliance on an exemption from registration under the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), pursuant to Section 4(a)(2) thereof. The common stock sold in the private placement has not been and will not be registered under the Securities Act, or any state or other applicable jurisdiction&#8217;s securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions&#8217; securities laws.<\/p>\n<p>This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.<\/p>\n<p><strong>About Lifecore Biomedical<\/strong><br \/>Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories. For more information about the Company, visit Lifecore\u2019s website at www.lifecore.com.<\/p>\n<p><strong>Important Cautions Regarding Forward-Looking Statements<\/strong><br \/>This press release contains forward-looking statements regarding future events and future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange Act of 1934. Words such as \u201canticipate\u201d, \u201cestimate\u201d, \u201cexpect\u201d, \u201cproject\u201d, \u201cplan\u201d, \u201cintend\u201d, \u201cbelieve\u201d, \u201cmay\u201d, \u201cmight\u201d, \u201cwill\u201d, \u201cshould\u201d, \u201ccan have\u201d, \u201clikely\u201d and similar expressions are used to identify forward-looking statements. All forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially, including such factors among others, as the Company\u2019s ability to successfully enact its business strategies, including with respect to installation, capacity generation and its ability to attract demand for its services, and its ability to expand its relationship with its existing customers or attract new customers; the impact of inflation on the Company\u2019s business and financial condition; changes in business conditions and general economic conditions both domestically and globally including rising interest rates and fluctuation in foreign currency exchange rates; the Company\u2019s ability to access sufficient capital to fund its business strategies; and other risk factors set forth from time to time in the Company\u2019s\u00a0SEC\u00a0filings, including, but not limited to, the Annual Report on Form 10-K for the year ended\u00a0May 26, 2024\u00a0(the \u201c2024 10-K\u201d). For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the\u00a0Securities and Exchange Commission, including the risk factors contained in the 2024 10-K. Forward-looking statements represent management\u2019s current expectations as of the date hereof and are inherently uncertain. Except as required by law, we do not undertake any obligation to update forward-looking statements made by us to reflect subsequent events or circumstances.<\/p>\n<pre>CONTACT: Contact Information:\r\n\r\nVida Strategic Partners\r\nStephanie Diaz (Investors)\r\n415-675-7401\r\nsdiaz@vidasp.com\r\n\r\nTim Brons (Media)\r\n415-675-7402\r\ntbrons@vidasp.com<\/pre>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ODM2ODhmYTktMGE4Yy00MGFhLThhNDItZmZjYzhiZTBiYWNmLTEwMTkzMjk=\/tiny\/Lifecore-Biomedical-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PIPE with New and Existing Investors Supports Working Capital and Operations CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) &#8212; Lifecore Biomedical, Inc. (\u201cLifecore\u201d), a fully integrated contract development and manufacturing organization (\u201cCDMO\u201d), today announced the closing of a $24.3 million private placement (\u201cPIPE\u201d) of 5,928,775 shares of its common stock at a price of $4.10 [&#8230;]\n","protected":false},"author":1,"featured_media":60221,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-60220","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock\" \/>\n<meta property=\"og:description\" content=\"PIPE with New and Existing Investors Supports Working Capital and Operations CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) &#8212; Lifecore Biomedical\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-04T12:00:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/10\/Lifecore-Biomedical-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock\",\"datePublished\":\"2024-10-04T12:00:29+00:00\",\"dateModified\":\"2024-10-04T12:00:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/\"},\"wordCount\":679,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/\",\"name\":\"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-10-04T12:00:29+00:00\",\"dateModified\":\"2024-10-04T12:00:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/","og_locale":"en_US","og_type":"article","og_title":"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock","og_description":"PIPE with New and Existing Investors Supports Working Capital and Operations CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) &#8212; Lifecore Biomedical","og_url":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-10-04T12:00:29+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/10\/Lifecore-Biomedical-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock","datePublished":"2024-10-04T12:00:29+00:00","dateModified":"2024-10-04T12:00:29+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/"},"wordCount":679,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/","url":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/","name":"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-10-04T12:00:29+00:00","dateModified":"2024-10-04T12:00:29+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/lifecore-biomedical-raises-24-3-million-in-private-placement-of-common-stock\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/60220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=60220"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/60220\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/60221"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=60220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=60220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=60220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}